Precision anti-infective technology focused on a microbiome sparing strategy. We target Clostridioides difficile infection (CDI), an antibiotic-associated infectious diarrheal disease, through oral delivery of a targeted Antisense Oligonucleotide.

Mastering surgical skills shouldn’t come at the cost of animals, high expenses, or limited training access. 3R SIMULATION reshapes animal surgical training with hyper-realistic simulators, offering a cost-effective, ethical, and accessible alternative to traditional methods. Our product enables professionals to hone skills anytime, anywhere, without sacrificing results. As demand for animal-free training grows, we are leading the shift towards a smarter, more responsible future in animal surgery education.

Senfina offers in vivo whole life drug discovery services for aging and age-related diseases based on a multi-feature high-throughput imaging platform using C. elegans as a model organism.

Our data-driven platform integrates high-throughput analytics and AI for next-generation drug discovery. We leverage novel insights into the foundational biologic pathways of neurodegenerative diseases to discover, evaluate, and develop disease-modifying therapeutics for Alzheimer’s disease, frontotemporal dementia (FTD) , amyotrophic lateral sclerosis (ALS), and other degenerative diseases of the nervous system.

Our novel gene editing removes the immunogenicity of human Pluripotent Stem Cells upon implantation into human organs. We have chosen Type 1 Diabetes as the initial indication to demonstrate the potential of our platform.

We have discovered new class of therapeutics that reduce the rate of cell growth in cancer and vascular lung diseases.

Occult Tethered Cord Syndrome (TCS) is a serious medical condition often detected before birth. If the spinal cord is not free it can result in several other urological problems and can result in a life-long disability.

The SeVA platform is a composite AI device that can be effectively deployed in hospital, nursing homes and home settings. It has the capability to track a patient’s mental and physical state and signal early signs of risks such as delirium, falls or impending illness. It provides emotional support to the patient and their family by indulging in a natural conversation and facilitating their needs. When fully deployed, the product can serve as a platform which allays worry for people and their caregivers and will reduce healthcare costs by identifying the early signs of severe illness.